跳至主要内容
临床试验/EUCTR2012-004824-39-GB
EUCTR2012-004824-39-GB进行中(未招募)1 期

The use of GnRH antagonist versus co-flare protocol for women with low ovarian reserve undergoing first cycle of in vitro fertilization - GnRH-antagonist vs co-flare protocol for women of low ovarian reserve

IVERSITY HOSPITALS OF LEICESTER NHS TRUST0 个研究点目标入组 4 人开始时间: 2014年6月9日最近更新:
适应症
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
4

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
Female

入选标准

  • Women 23-39 years, with body mass index (BMI) of 19-30 Kg/m2, who are ready to start their first IVF treatment cycle with or without intracytoplasmic sperm injection (ICSI) and who have AMH between 3.08-21.97 pmol/L and day 2-4 serum FSH <15 IU/L. (These AMH levels are compatible with reduced ovarian reserve on Gen II assay results).
  • All women will have 2 ovaries identified on a previous scan.
  • Are the trial subjects under 18? no
  • Number of subjects for this age range: 0
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 60
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range 0

排除标准

  • Previous controlled ovarian stimulation for IVF
  • Day 2-4 serum FSH levels = 15 iu/L
  • AMH > 21.97 or < 3.08 pmol/L
  • Known allergies to study medications
  • Recognised endocrine abnormalities of the hypothalamic pituitary axis such as hypogonadism and hyperprolactinaemia
  • Unsuitable for IVF/ICSI on welfare of the child assessment
  • Concurrent participation in another drug trial

研究者

发起方
IVERSITY HOSPITALS OF LEICESTER NHS TRUST

相似试验